U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606898) titled 'Fractional Exhaled Nitric Oxide as Possible Non - Invasive Biomarker to Assess Obstructive Sleep Apnea Severity' on May 12.
Brief Summary: Aim of work
1. Primary aim: Asses correlation between FeNO level, OSA severity
2. Secondary aim: Clarifying FeNO's role as a biomarker to assess airway inflammation, Cut off value prediction to moderate and severe OSA and its potential significance to improve clinical management strategies for OSA patients.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
Obstructive Sleep Apnea (OSA)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tanta University
Information provided by ...